Bruce Cameron Conway
No reply on file from Bruce Cameron Conway on this matter.
Claims entered
No claim has been entered on this docket.
1 filed · 1 on the record. The chronology below carries every filing, docket event and outcome — open a row there for its source.
Open to posting — anyone may add to this file, subject to the review queue.
The chronology
Gov, Institution and Public name who produced a document; Event marks a thing that happened, not a document.
By when it happened. Rows with no date on their face are shown as undated, not guessed. Hover, focus or tap a row for its full detail.
Opened at stage filed
U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. 26568 / June 16, 2026 Securities and Exchange Commission v. Bruce Cameron Conway , No. 3:35-cv-2101 (N.D. Tex. filed Aug. 7, 2025) SEC Settles Litigation with Texas Resident Charged with Insider Trading On June 15, the Securities and Exchange Commission filed a consent and proposed final judgment as to defendant Bruce Cameron Conway, whom the SEC previously charged with insider trading. The SEC’s complaint, filed on August 7, 2025 in the U.S. District Court for the Northern District of Texas, alleged that in July 2020, after agreeing to confidentiality terms, Conway obtained material nonpublic information regarding a privately-held biotechnology firm in which Conway was invested and its plan to merge with Cancer Genetics. The complaint further alleged Conway purchased Cancer Genetics shares on the basis of that information in fifteen accounts belonging to him, his family members, and family-owned trusts. As alleged, on August 24, 2020, the merger was publicly announced, the price of Cancer Genetics stock rose by 215 percent from the previous day’s closing price, and Conway began selling his Cancer Genetics shares. Without admitting the allegations in the SEC’s complaint, Conway consented to the entry of a final judgment, subject to court approval, in which he agreed to be permanently enjoined from violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder; and to pay disgorgement of $60,201.95, prejudgment interest of $19,461.39, and a civil penalty of $160,936.22. The SEC’s litigation was conducted by John Dwyer and Jodanna Haskins, under the supervision of Gregory A. Kasper. The SEC’s investigation was conducted by John Dwyer and supervised by Kimberly Frederick and Nicholas Heinke, all of the SEC’s Denver Regional Office. The SEC appreciates the assistance of the Financial Industry Regulatory Authority. Resources <ul class="field
No crime on the record yet.
No statutes on the record yet.
"District Court for the Northern District of Texas, alleged that in July 2020, after agreeing to confidentiality terms, Conway obtained material nonpublic information regarding a privately-held biotechnology firm in which Conway was invested and its plan to merge with Cancer Genetics."
"Tex. filed Aug. 7, 2025) SEC Settles Litigation with Texas Resident Charged with Insider Trading On June 15, the Securities and Exchange Commission filed a consent and proposed final judgment as to defendant Bruce Cameron Conway, whom the SEC previously charged with insider trading."
"Bruce Cameron Conway , No. 3:35-cv-2101 (N.D."
No parties on the record yet.
"Without admitting the allegations in the SEC’s complaint, Conway consented to the entry of a final judgment, subject to court approval, in which he agreed to be permanently enjoined from violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder; and to pay disgorgement of $60,201.95, prejudgment interest of $19,461.39, and a civil penalty of $160,936.22."
"Without admitting the allegations in the SEC’s complaint, Conway consented to the entry of a final judgment, subject to court approval, in which he agreed to be permanently enjoined from violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder; and to pay disgorgement of $60,201.95, prejudgment interest of $19,461.39, and a civil penalty of $160,936.22."
"Without admitting the allegations in the SEC’s complaint, Conway consented to the entry of a final judgment, subject to court approval, in which he agreed to be permanently enjoined from violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder; and to pay disgorgement of $60,201.95, prejudgment interest of $19,461.39, and a civil penalty of $160,936.22."